• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma.

作者信息

Dittus Christopher, Miller Jordan A, Wehbie Robert, Castillo Jorge J

机构信息

Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.

出版信息

Br J Haematol. 2022 Jul;198(2):e32-e34. doi: 10.1111/bjh.18228. Epub 2022 May 4.

DOI:10.1111/bjh.18228
PMID:35506301
Abstract
摘要

相似文献

1
Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma.达雷妥尤单抗联合异环磷酰胺、卡铂和依托泊苷治疗复发的浆母细胞淋巴瘤。
Br J Haematol. 2022 Jul;198(2):e32-e34. doi: 10.1111/bjh.18228. Epub 2022 May 4.
2
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.达雷妥尤单抗联合异环磷酰胺、卡铂和依托泊苷治疗二线复发或难治性经典型霍奇金淋巴瘤：一项单中心、1/2 期研究。
Lancet Haematol. 2021 Aug;8(8):e562-e571. doi: 10.1016/S2352-3026(21)00170-8.
3
Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.异环磷酰胺-卡铂-依托泊苷（ICE）与阿糖胞苷-顺铂-地塞米松（DHAP）作为复发或难治性淋巴瘤患者挽救性化疗的比较
Cancer Invest. 2008 May;26(4):401-6. doi: 10.1080/07357900701788098.
4
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.门诊分次给予异环磷酰胺、卡铂和依托泊苷作为复发和难治性非霍奇金淋巴瘤及霍奇金淋巴瘤的挽救治疗。
Ann Oncol. 2006 May;17 Suppl 4:iv25-30. doi: 10.1093/annonc/mdj995.
5
Bortezomib- and Lenalidomide-Based Treatment of Refractory Plasmablastic Lymphoma.硼替佐米和来那度胺联合治疗难治性浆母细胞淋巴瘤。
Oncol Res Treat. 2020;43(3):112-116. doi: 10.1159/000504608. Epub 2019 Dec 16.
6
Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: a Pediatric Oncology Group phase II study.异环磷酰胺/卡铂/依托泊苷（ICE），一种治疗儿童复发性恶性非霍奇金淋巴瘤的有效挽救疗法：一项儿科肿瘤学组II期研究。
Med Pediatr Oncol. 1999 Mar;32(3):225-6. doi: 10.1002/(sici)1096-911x(199903)32:3<225::aid-mpo12>3.0.co;2-n.
7
Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.异环磷酰胺和依托泊苷用于晚期、复发或难治性原发性皮肤T细胞淋巴瘤
Br J Dermatol. 2020 Nov;183(5):961-962. doi: 10.1111/bjd.19220. Epub 2020 Jul 13.
8
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.利妥昔单抗联合异环磷酰胺、卡铂和依托泊苷化疗用于复发/难治性B细胞（CD20+）非霍奇金淋巴瘤及成熟B细胞急性淋巴细胞白血病患儿的研究：儿童肿瘤协作组报告
Pediatr Blood Cancer. 2009 Feb;52(2):177-81. doi: 10.1002/pbc.21753.
9
Salvage chemotherapy for relapsed and resistant lymphoma with a carboplatin containing schedule--EPIC.含卡铂方案的挽救性化疗用于复发和难治性淋巴瘤——EPIC研究
Hematol Oncol. 1994 May-Jun;12(3):125-8. doi: 10.1002/hon.2900120304.
10
High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.卡铂、依托泊苷和异环磷酰胺高剂量化疗后自体干细胞救援治疗复发或难治性恶性淋巴瘤患者：一项I/II期研究。
Bone Marrow Transplant. 1997 Dec;20(11):953-9. doi: 10.1038/sj.bmt.1701002.

引用本文的文献

1
[Chinese expert consensus on the diagnosis and treatment of plasmablastic lymphoma (2025)].[2025年浆母细胞淋巴瘤诊断与治疗中国专家共识]
Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):295-301. doi: 10.3760/cma.j.cn121090-20241213-00566.
2
B-cell maturation antigen expression and clinical features of plasmablastic lymphoma.浆母细胞淋巴瘤的B细胞成熟抗原表达及临床特征
EJHaem. 2024 Jan 18;5(1):285-289. doi: 10.1002/jha2.807. eCollection 2024 Feb.
3
Primary refractory plasmablastic lymphoma: A precision oncology approach.原发性难治性浆母细胞淋巴瘤：一种精准肿瘤学方法。
Front Oncol. 2023 Feb 27;13:1129405. doi: 10.3389/fonc.2023.1129405. eCollection 2023.
4
Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.硼替佐米、来那度胺和地塞米松联合诱导复发/难治性浆母细胞淋巴瘤完全缓解：一种潜在新型治疗方法的病例报告。
Curr Oncol. 2022 Jul 18;29(7):5042-5053. doi: 10.3390/curroncol29070399.